Spinnaker Biosciences Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$667K
- Investors
-
1
Spinnaker Biosciences General Information
Description
Developer of nanoporous silicon particles intended for controlled-release drug delivery. The company's process allows the manufacture of nano-pores precisely tuned to accommodate the dimensions of a drug of interest and provides a protective cage for the drug and yields control over the rate of release of the drug and the dissolution of the particles, enabling healthcare professionals to develop composite materials to make controlled release drug delivery vehicles.
Contact Information
Website
www.spinnakerbiosciences.comCorporate Office
- 665 San Rodolfo Drive
- Suite 124-165
- Solana Beach, CA 92075
- United States
Corporate Office
- 665 San Rodolfo Drive
- Suite 124-165
- Solana Beach, CA 92075
- United States
Spinnaker Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 06-Dec-2024 | $667K | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 31-Dec-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Feb-2014 | $159K | $1M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 14-Dec-2010 | $1M | $1M | Completed | Startup |
Spinnaker Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,700,000 | $0.000100 | 8% | $1 | $1 | 1x | $1 | 8.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Spinnaker Biosciences Patents
Spinnaker Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3021001-A1 | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents | Pending | 14-Apr-2016 | ||
| EP-3442540-A4 | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents | Pending | 14-Apr-2016 | ||
| EP-3442540-A1 | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents | Pending | 14-Apr-2016 | ||
| AU-2017250300-A1 | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents | Active | 14-Apr-2016 | ||
| US-20210177770-A1 | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents | Pending | 14-Apr-2016 | A61K47/6923 |
Spinnaker Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Spinnaker Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government |
Spinnaker Biosciences FAQs
-
When was Spinnaker Biosciences founded?
Spinnaker Biosciences was founded in 2009.
-
Where is Spinnaker Biosciences headquartered?
Spinnaker Biosciences is headquartered in Solana Beach, CA.
-
What is the size of Spinnaker Biosciences?
Spinnaker Biosciences has 4 total employees.
-
What industry is Spinnaker Biosciences in?
Spinnaker Biosciences’s primary industry is Drug Delivery.
-
Is Spinnaker Biosciences a private or public company?
Spinnaker Biosciences is a Private company.
-
What is the current valuation of Spinnaker Biosciences?
The current valuation of Spinnaker Biosciences is .
-
What is Spinnaker Biosciences’s current revenue?
The current revenue for Spinnaker Biosciences is .
-
How much funding has Spinnaker Biosciences raised over time?
Spinnaker Biosciences has raised $2.57M.
-
Who are Spinnaker Biosciences’s investors?
U.S. Department of Health and Human Services has invested in Spinnaker Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
